R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25. [PDF]
Arora P, Ramagopalan SV.
europepmc +1 more source
Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real-World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps. [PDF]
Cresswell K +12 more
europepmc +1 more source
Comparative Analysis of Pathology Foundation Models for Automated Detection of Tertiary Lymphoid Structures in Hematoxylin-and-Eosin-Stained Digital Pathology Images. [PDF]
Guan M +9 more
europepmc +1 more source
GENERATIVE AI TOWARDS A COMPARATIVE ANALYSIS OF HOSPITALIZATION RATES AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH INFLIXIMAB, VEDOLIZUMAB, AND TOFACITINIB IN THE PUBLIC HEALTHCARE SYSTEM IN BRAZIL: A NATIONWIDE STUDY. [PDF]
Valverde DA +4 more
europepmc +1 more source
Advancing real-world evidence harmonization: lessons from the UK, EMA and global policy frameworks. [PDF]
Sagkriotis A.
europepmc +1 more source
Integrating Artificial Intelligence, Circulating Tumor DNA, and Real-World Evidence to Optimize Hematologic Clinical Trials: Toward Adaptive and Learning Trial Designs. [PDF]
Mahmoud AM +4 more
europepmc +1 more source
The Enactment and Implementation of Korea's Digital Medical Products Act: A Comparative Study Exploring Policy Implications. [PDF]
Chung J, Shin Y, Kim G, Lee M, Shin J.
europepmc +1 more source
From In Silico Hypothesis to Validation: The Role of Real-World Evidence in the Preliminary Verification of AI-Generated Drug-Repositioning Candidates: A Comprehensive Review. [PDF]
Gałuszewski M +4 more
europepmc +1 more source
Trust and trade: patient perspectives on the ethics of real-world data monetisation. [PDF]
Sagkriotis A.
europepmc +1 more source
Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping review. [PDF]
Oikonomidi T +15 more
europepmc +1 more source

